Study of Tofacitinib in Refractory Dermatomyositis

NCT03002649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Dermatomyositis

Interventions

DRUG: Tofacitinib

Sponsor

Johns Hopkins University

Collaborators

[object Object]